Literature DB >> 25433757

Serial intracameral bevacizumab for uveitis-glaucoma-hyphema syndrome: a case report.

Lia Rech1, Lisa Heckler2, Karim F Damji2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25433757     DOI： 10.1016/j.jcjo.2014.09.010

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN： 0008-4182            Impact factor:   1.882


× No keyword cloud information.
  3 in total

Review 1.  Uveitis-Glaucoma-Hyphaema Syndrome. General review.

Authors:  Mihail Zemba; Georgiana Camburu
Journal:  Rom J Ophthalmol       Date:  2017 Jan-Mar

2.  A novel method of using transillumination, conjunctival markings and Pascal solid state laser to treat Uveitis-Glaucoma-Hyphema syndrome.

Authors:  Baltej Dhillon; Sarah Madison Duff-Lynes; Charles Richard Blake
Journal:  Am J Ophthalmol Case Rep       Date:  2022-01-20

3.  Diode laser transscleral cyclophotocoagulation for uveitis-glaucoma-hyphema syndrome: A case report.

Authors:  Zhengfeng Liu; Feng Zhang; Ying Wen; Xiujuan Du; Xuemei Pan; Hongsheng Bi
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.